Login Register Cart 0
Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Pulmonary Rehabilitation in COVID-19: The Contribution of other Chronic Lung Syndromes for the Intervention of a Novel Disease

Author(s): Vicente Benavides-Córdoba, Diana Guerrero-Jaramillo and Jhonatan Betancourt-Peña*

Volume 16, Issue 4, 2020

Page: [207 - 212] Pages: 6

DOI: 10.2174/1573398X17666210129124433

Price: $65

Abstract

COVID-19 has spread throughout the world causing a significant number of cases of pneumonia and SARS. Patients with COVID-19 may also have other cardiovascular, respiratory, and neuromuscular disorders. These multisystemic complications present the need for comprehensive interventions focused on improving symptoms, functional capacity, and quality of life. Pulmonary rehabilitation has the potential to offer some of these benefits. However, the evidence related to specific aspects of pulmonary rehabilitation evaluation and intervention in COVID19 is limited. We have learned from experiences with other types of chronic lung diseases that have used pulmonary rehabilitation successfully. While the evidence of rehabilitation emerges in COVID-19, it is necessary to establish some initial recommendations, prepared according to the sequelae found until now.

Keywords: COVID-19, lung diseases, rehabilitation, exercise, hypoxia, pleural effusion.

Next »
Graphical Abstract

[1]
WHO. Rolling updates on coronavirus disease (COVID-19). 2020. Avaiable from: www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
[2]
Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 2020; 19(3): 149-50.
[http://dx.doi.org/10.1038/d41573-020-00016-0] [PMID: 32127666]
[3]
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223): 507-13.
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[4]
Jaffri A, Jaffri UA. Post-Intensive care syndrome and COVID-19: crisis after a crisis? Heart Lung 2020; 49(6): 883-4.
[http://dx.doi.org/10.1016/j.hrtlng.2020.06.006] [PMID: 32690219]
[5]
Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect 2020; 80(6): e14-8.
[PMID: 32171866]
[6]
Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract 2020; 39: 101166.
[PMID: 32379637]
[7]
Zhao HM, Xie YX, Wang C. Chinese association of rehabilitation medicine; Respiratory Rehabilitation Committee of Chinese Association of Rehabilitation Medicine; Cardiopulmonary Rehabilitation Group of Chinese Society of Physical Medicine and Rehabilitation. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chin Med J (Engl) 2020; 133(13): 1595-602.
[PMID: 32251002]
[8]
Ding Q, Lu P, Fan Y, Xia Y, Liu M. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol 2020; 92(9): 1549-55.
[PMID: 32196707]
[9]
Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol 2020; 75(18): 2352-71.
[http://dx.doi.org/10.1016/j.jacc.2020.03.031] [PMID: 32201335]
[10]
Akhmerov A, Marbán E. COVID-19 and the Heart. Circ Res 2020; 126(10): 1443-55.
[PMID: 32252591]
[11]
Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 2020; 295(1): 202-7.
[PMID: 32017661]
[12]
Xie L, Liu Y, Fan B, et al. Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge. Respir Res 2005; 6(1): 5.
[PMID: 15638943]
[13]
Wong HYF, Lam HYS, Fong AHT, Leung ST, Chin TWY, Lo CSY, et al. Frequency and distribution of chest radiographic findings in COVID-19 positive patients. Radiology 2020; 201160.
[http://dx.doi.org/10.1148/radiol.2020201160] [PMID: 32216717]
[14]
Huang Y, Wang S, Liu Y, Zhang Y, Zheng C, Zheng Y, et al. A preliminary study on the ultrasonic manifestations of peripulmonary lesions of non-critical novel coronavirus pneumonia (COVID-19). SSRN 2020; 3544750.
[15]
Xu YH, Dong JH, An WM, et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect 2020; 80(4): 394-400.
[PMID: 32109443]
[16]
Chan KS, Zheng JP, Mok YW, et al. SARS: prognosis, outcome and sequelae. Respirology 2003; 8(Suppl.): S36-40.
[PMID: 15018132]
[17]
Xie L, Liu Y, Xiao Y, et al. Follow-up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge. Chest 2005; 127(6): 2119-24.
[PMID: 15947329]
[18]
Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol 2011; 11(1): 37.
[PMID: 21435231]
[19]
Ong KC, Ng AWK, Lee LSU, et al. 1-year pulmonary function and health status in survivors of severe acute respiratory syndrome. Chest 2005; 128(3): 1393-400.
[http://dx.doi.org/10.1378/chest.128.3.1393] [PMID: 16162734]
[20]
Wischmeyer PE, Puthucheary Z, San Millán I, Butz D, Grocott MPW. Muscle mass and physical recovery in ICU: innovations for targeting of nutrition and exercise. Curr Opin Crit Care 2017; 23(4): 269-78.
[http://dx.doi.org/10.1097/MCC.0000000000000431] [PMID: 28661414]
[21]
Hui DS, Joynt GM, Wong KT, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax 2005; 60(5): 401-9.
[http://dx.doi.org/10.1136/thx.2004.030205] [PMID: 15860716]
[22]
Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020; 58(7): 1021-8.
[http://dx.doi.org/10.1515/cclm-2020-0369] [PMID: 32286245]
[23]
Grasselli G, Zangrillo A, Zanella A, et al. COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020; 323(16): 1574-81.
[http://dx.doi.org/10.1001/jama.2020.5394] [PMID: 32250385]
[24]
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020; 17(5): 259-60.
[PMID: 32139904]
[25]
Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol 2007; 170(4): 1136-47.
[PMID: 17392154]
[26]
Xi ZJHHH, Zhi Z. Chinese Association of Rehabilitation Medicine, Respiratory rehabilitation committee of Chinese Association of Rehabilitation Medicine, Cardiopulmonary rehabilitation Group of Chinese Society of Physical Medicine and Rehabilitation. In Recommendations for respiratory rehabilitation of COVID-19 in adults. Zhonghua Jie He He Hu Xi Za Zhi 2020; 43: E029.
[27]
Lim PA, Ng YS, Tay BK. Impact of a viral respiratory epidemic on the practice of medicine and rehabilitation: severe acute respiratory syndrome. Arch Phys Med Rehabil 2004; 85(8): 1365-70.
[http://dx.doi.org/10.1016/j.apmr.2004.01.022] [PMID: 15295768]
[28]
American Association of Cardiovascular Pulmonary Rehabilitation. Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs. 4th ed. 2004.
[29]
Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77(6): 683-90.
[http://dx.doi.org/10.1001/jamaneurol.2020.1127] [PMID: 32275288]
[30]
Borg K, Stam H. Editorial: Covid-19 and Physical and Rehabilitation Medicine. J Rehabil Med 2020; 52(4): jrm00045.
[http://dx.doi.org/10.2340/16501977-2679] [PMID: 32286673]
[31]
Ahmed H, Patel K, Greenwood DC, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J Rehabil Med 2020; 52(5): jrm00063.
[PMID: 32449782]
[32]
Hull JH, Lloyd JK, Cooper BG. Lung function testing in the COVID-19 endemic. Lancet Respir Med 2020; 8(7): 666-7.
[PMID: 32479795]
[33]
Pulvirenti F, Cinetto F, Milito C, et al. Health-related-quality of life in common variable immunodeficiency italian patients switched to remote assistance during the COVID-19 pandemic. J Allergy Clin Immunol Pract 2020; 8(6): 1894-1899.e2.
[PMID: 32278865]
[34]
Hopkins RO, Weaver LK, Collingridge D, Parkinson RB, Chan KJ, Orme JF Jr. Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome. Am J Respir Crit Care Med 2005; 171(4): 340-7.
[http://dx.doi.org/10.1164/rccm.200406-763OC] [PMID: 15542793]
[35]
Rosińczuk J, Przyszlak M, Uchmanowicz I. Sociodemographic and clinical factors affecting the quality of life of patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2018; 13: 2869-82.
[PMID: 30254434]
[36]
Mejia R, Ward J, Lentine T, Mahler DA. Target dyspnea ratings predict expected oxygen consumption as well as target heart rate values. Am J Respir Crit Care Med 1999; 159(5 Pt 1): 1485-9.
[PMID: 10228115]
[37]
Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(10): 1005-12.
[PMID: 14999112]
[38]
Zanini A, Aiello M, Cherubino F, et al. The one repetition maximum test and the sit-to-stand test in the assessment of a specific pulmonary rehabilitation program on peripheral muscle strength in COPD patients. Int J Chron Obstruct Pulmon Dis 2015; 10: 2423-30.
[http://dx.doi.org/10.2147/COPD.S91176] [PMID: 26648705]
[39]
Tarigan AP, Ananda FR, Pandia P, Sinaga BY, Maryaningsih M, Anggriani A. The impact of upper limb training with breathing maneuver in lung function, functional capacity, dyspnea scale, and quality of life in patient with stable chronic obstructive of lung disease. Open Access Maced J Med Sci 2019; 7(4): 567-72.
[http://dx.doi.org/10.3889/oamjms.2019.113] [PMID: 30894913]
[40]
Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014; 44(6): 1428-46.
[PMID: 25359355]
[41]
Zanini A, Crisafulli E, D’Andria M, et al. Minimum clinically important difference in 30-s sit-to-stand test after pulmonary rehabilitation in subjects with COPD. Respir Care 2019; 64(10): 1261-9.
[PMID: 31270178]
[42]
Beck AT, Brown GK, Steer RA, Kuyken W, Grisham J. Psychometric properties of the beck self-esteem scales. Behav Res Ther 2001; 39(1): 115-24.
[PMID: 11125720]
[43]
Hsieh MJ, Lee WC, Cho HY, et al. Recovery of pulmonary functions, exercise capacity, and quality of life after pulmonary rehabilitation in survivors of ARDS due to severe influenza A (H1N1) pneumonitis. Influenza Other Respir Viruses 2018; 12(5): 643-8.
[http://dx.doi.org/10.1111/irv.12566] [PMID: 29676537]
[44]
Jones RC, Wang X, Harding S, Bott J, Hyland M. Educational impact of pulmonary rehabilitation: Lung Information Needs Questionnaire. Respir Med 2008; 102(10): 1439-45.
[PMID: 18676136]
[45]
Klok FA, Boon GJAM, Barco S, et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J 2020; 56(1): 2001494.
[PMID: 32398306]
[46]
Caccialanza R, Laviano A, Lobascio F, et al. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol. Nutrition 2020; 74: 110835.
[http://dx.doi.org/10.1016/j.nut.2020.110835] [PMID: 32280058]
[47]
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8(4): 420-2.
[http://dx.doi.org/10.1016/S2213-2600(20)30076-X] [PMID: 32085846]
[48]
Tansey CM, Louie M, Loeb M, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med 2007; 167(12): 1312-20.
[PMID: 17592106]
[49]
Nakazawa A, Cox NS, Holland AE. Current best practice in rehabilitation in interstitial lung disease. Ther Adv Respir Dis 2017; 11(2): 115-28.
[http://dx.doi.org/10.1177/1753465816676048] [PMID: 28150539]
[50]
Goldstein RS, Hill K, Brooks D, Dolmage TE. Pulmonary rehabilitation: a review of the recent literature. Chest 2012; 142(3): 738-49.
[PMID: 22948578]
[51]
Iepsen UW, Jørgensen KJ, Ringbæk T, Hansen H, Skrubbeltrang C, Lange P. A combination of resistance and endurance training increases leg muscle strength in COPD: An evidence-based recommendation based on systematic review with meta-analyses. Chron Respir Dis 2015; 12(2): 132-45.
[PMID: 25767138]
[52]
Hill K, Cavalheri V, Mathur S, et al. Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2018; 5(5): CD010821.
[PMID: 29845600]
[53]
Spruit MA, Holland AE, Singh SJ, Tonia T, Wilson KC, Troosters T. COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European Respiratory Society and American Thoracic Society-coordinated International Task Force. Eur Respir J 2020; 2002197.
[http://dx.doi.org/10.1183/13993003.02197-2020] [PMID: 32817258]
[54]
Gautam AP, Arena R, Dixit S, Borghi-Silva A. Pulmonary rehabilitation in COVID-19 pandemic era: The need for a revised approach. Respirology 2020; 25(12): 1320-2.
[http://dx.doi.org/10.1111/resp.13946] [PMID: 32954580]
[55]
Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clinical Infectious Diseases 2020.
[56]
Lyons C, Callaghan M. The use of high-flow nasal oxygen in COVID-19. Anaesthesia 2020; 75(7): 843-7.
[http://dx.doi.org/10.1111/anae.15073] [PMID: 32246843]
[57]
Butler MJ, Barrientos RM. The impact of nutrition on COVID-19 susceptibility and long-term consequences. Brain Behav Immun 2020.
[58]
Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health 2020; 17(5): 1729.
[http://dx.doi.org/10.3390/ijerph17051729] [PMID: 32155789]
[59]
Rueda-Garrido JC, Vicente-Herrero MT, Del Campo MT, et al. Return to work guidelines for the COVID-19 pandemic. Occup Med (Lond) 2020; 70(5): 300-5.
[http://dx.doi.org/10.1093/occmed/kqaa099] [PMID: 32476022]
[60]
Puhan MA, Büsching G, Schünemann HJ, VanOort E, Zaugg C, Frey M. Interval versus continuous high-intensity exercise in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2006; 145(11): 816-25.
[http://dx.doi.org/10.7326/0003-4819-145-11-200612050-00006] [PMID: 17146066]
[61]
McKeough ZJ, Velloso M, Lima VP, Alison JA. Upper limb exercise training for COPD. Cochrane Database Syst Rev 2016; 11(11): CD011434.
[PMID: 27846347]
[62]
Vieira PJ, Chiappa AMG, Cipriano G Jr, Umpierre D, Arena R, Chiappa GR. Neuromuscular electrical stimulation improves clinical and physiological function in COPD patients. Respir Med 2014; 108(4): 609-20.
[http://dx.doi.org/10.1016/j.rmed.2013.12.013] [PMID: 24418570]
[63]
Vivodtzev I, Debigaré R, Gagnon P, et al. Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial. Chest 2012; 141(3): 716-25.
[http://dx.doi.org/10.1378/chest.11-0839] [PMID: 22116795]
[64]
Torres del Castillo N, Paredes L, Shek N, Hurtado-Gutierrez H, Betancourt-Peña J. Benefits of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis and other interstitial lung diseases. Chest 2017; 152(4): A982.
[65]
Roman MA, Rossiter HB, Casaburi R. Exercise, ageing and the lung. Eur Respir J 2016; 48(5): 1471-86.
[http://dx.doi.org/10.1183/13993003.00347-2016] [PMID: 27799391]
[66]
Ferreira A, Garvey C, Connors GL, et al. Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest 2009; 135(2): 442-7.
[PMID: 18849399]
[67]
Laviano A, Koverech A, Zanetti M. Nutrition support in the time of SARS-CoV-2 (COVID-19). Nutrition 2020; 74: 110834.
[http://dx.doi.org/10.1016/j.nut.2020.110834] [PMID: 32276799]
[68]
Popa-Velea O, Purcarea VL. Psychological intervention - a critical element of rehabilitation in chronic pulmonary diseases. J Med Life 2014; 7(2): 274-81.
[PMID: 25408739]
[69]
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Mil Med Res 2020; 7(1): 1-10.
[http://dx.doi.org/10.1186/s40779-020-00240-0] [PMID: 31928528]
[70]
Wang TJ, Chau B, Lui M, Lam GT, Lin N, Humbert S. Physical medicine and rehabilitation and pulmonary rehabilitation for COVID-19. Am J Phys Med Rehabil 2020; 99(9): 769-74.
[http://dx.doi.org/10.1097/PHM.0000000000001505] [PMID: 32541352]
[71]
Gutenbrunner C, Stokes EK, Dreinhöfer K, et al. Why Rehabilitation must have priority during and after the COVID-19-pandemic: A position statement of the Global Rehabilitation Alliance. J Rehabil Med 2020; 52(7): jrm00081.
[PMID: 32719884]

Rights & Permissions Print Cite
Article Metrics
17
© 2024 Bentham Science Publishers | Privacy Policy